Late effects of antileukemic treatment.
Increasing numbers of childhood ALL survivors have increased the need to assess the physical and psychosocial functioning of this group in a careful manner. This article reviews data on the frequency and types of second malignancies, structural and functional changes in the central nervous system, endocrine effects on growth and reproduction, and psychosocial aspects of development. Most long-term survivors of ALL do not have serious or life-threatening medical problems; however, medical and psychosocial problems may not be insignificant and may require coordinated management over prolonged periods.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002493:Central Nervous System Diseases / Q000209:etiology; D002648:Child; D003072:Cognition Disorders / Q000209:etiology; D003131:Combined Modality Therapy; D004700:Endocrine System Diseases / Q000209:etiology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000628:therapy*; D009378:Neoplasms, Multiple Primary; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors; D013997:Time Factors
D000970:Antineoplastic Agents